The Respiratory Diagnostic Devices Market Outlook to 2016

Introduction

This report covers the epidemiology of the key respiratory disorders forecasting this to 2016. The report then goes on to give in depth analysis of the major diagnostic technologies including: blood gas analyzers, pulse oximeters, spirometers, full spectrum testing equipment, and polysomnographs. For each of these technology types an overview is given of the leading players and their products.

Features and benefits

• Discover the epidemiology of key respiratory disorders with this report's forecasts through to 2016.
• Analyze the key challenges facing companies in the respiratory diagnostics devices and discover the responses to them from the leading players.
• Discover the key types and differentiating features of the most important respiratory diagnostic devices
• Identify the leading players in each of the key market segments and study their product portfolios.
• Use this report's forecasts to 2016 to identify which market segments are going to grow most quickly and thus where to invest.

Highlights

More than two billion people suffer from respiratory disorders, with over half of these people suffering from acute respiratory distress syndrome or chronic obstructive pulmonary disease (COPD). COPD is forecast to be the third biggest cause of death 2020. The prompt diagnosis of these disorders is therefore crucial to allow effective treatment.

BGA is well differentiated in analytical technology and by end user deployment. BGAs employ a range of technologies functioning on electrochemical and colorimetric detection. From an end use perspective BGAs are available as bench top/stationary laboratory consoles and handheld point of care testing (POCT) consoles.

Product differentiation in PSG equipment is mostly on the basis of point of deployment of the device in the healthcare chain. The most advanced devices are stationary laboratory installed consoles operated under the supervision of a trained professional.

Your key questions answered

• What is the patient potential for respiratory disorders including Asthma, COPD, ARDS, cystic fibrosis, pneumonia, and sleep apnea?
• What is the size of the market for blood gas analyzers, pulse oximeters, spirometers, and sleep diagnostic equipment and what will it be in 2016?
• Who are the leading players in the key segments of the respiratory diagnostic devices market and what are their product portfolios?
• Who are the end users for the various diagnostic devices are and what their needs are?
• What are the drivers and resistors of the respiratory diagnostics device market?